News & Updates
Filter by Specialty:
Financial aid helps improve survival of indigent patients with breast cancer
A trend towards a favourable overall (OS) and disease-free survival (DFS) at 21 months follow-up has been observed among patients with early breast cancer enrolled to a government program that grants medicines access to indigent individuals, reports a study presented at ASCO Breakthrough 2023.
Financial aid helps improve survival of indigent patients with breast cancer
20 Aug 2023
Does concomitant TKI‒SSRI use increase risk of bleeding, thrombotic events?
Patients with chronic myeloid leukaemia (CML) who are being treated with both tyrosine kinase inhibitors (TKIs) and selective serotonin reuptake inhibitors (SSRIs) do not appear to be at greater total risk of bleeding or thrombotic events than those on TKIs only, reveals a study. However, concomitant use of TKIs and SSRIs may elevate the risk of intracranial bleeding.
Does concomitant TKI‒SSRI use increase risk of bleeding, thrombotic events?
19 Aug 2023
Targeted approaches for T2D prevention, treatment needed for different Asian ethnic groups
Asians of different ethnicities have different risk factors for type 2 diabetes (T2D), according to a study, highlighting the potential value of tailored prevention and treatment strategies.
Targeted approaches for T2D prevention, treatment needed for different Asian ethnic groups
19 Aug 2023
OGTT-based model predicts GDM in pregnant women
The current diagnostic criteria being used to predict gestational diabetes mellitus (GDM) is not fully reliable, but adding oral glucose tolerance test (OGTT) to the model may improve early prediction of GDM, according to a study.
OGTT-based model predicts GDM in pregnant women
18 Aug 2023
Fezolinetant reduces menopause-related vasomotor symptoms
Treatment with fezolinetant 30 and 45 mg daily provides relief from moderate-to-severe vasomotor symptoms (VSM) associated with menopause, suggests a study.
